Patents Assigned to NuPathe, Inc.
  • Implants for the treatment of dopamine associated states
    Patent number: 10278916
    Abstract: Biodegradable implants comprising dopamine modulating compounds are described.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: May 7, 2019
    Assignees: NuPathe Inc., The Trustees of the University of Pennsylvania
    Inventors: Terri B. Sebree, Steven J. Siegel
  • Electronic control of drug delivery system
    Patent number: 8983594
    Abstract: In an exemplary embodiment, a drug delivery device for driving an electrotransport current through a body surface of a user is provided. The device includes a patch with two electrodes and one or more reservoirs storing a therapeutic agent. The one or more reservoirs release the therapeutic agent into the body surface of the user when the reservoirs are positioned over the electrodes to form an electrical path for the electrotransport current. The device includes a controller which controls a controllable power supply to drive the electrotransport current through the body surface of the user in a predetermined profile.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: March 17, 2015
    Assignee: NuPathe, Inc.
    Inventors: David Saar, Bogdan Mariusz Baudis, Rainuka Gupta, Vaishali Vilas Kamat, Matthew Kent Reich, Rajagopalan Srinivasan
  • Methods for iontophoretically treating nausea and migraine
    Patent number: 8845612
    Abstract: Methods for treating nausea and migraine by iontophoretically administering triptan compounds are provided.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: September 30, 2014
    Assignee: NuPathe Inc.
    Inventors: Terri B. Sebree, Mark Pierce, Carol O'Neill
  • PHARMACOKINETICS OF IONTOPHORETIC SUMATRIPTAN ADMINISTRATION
    Publication number: 20140236069
    Abstract: Improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan are described.
    Type: Application
    Filed: February 20, 2014
    Publication date: August 21, 2014
    Applicant: NuPathe, Inc.
    Inventors: Terri B. Sebree, Mark Pierce, Carol O'Neill
  • IMPLANTS FOR THE TREATMENT OF DOPAMINE ASSOCIATED STATES
    Publication number: 20140221451
    Abstract: Biodegradable implants comprising dopamine modulating compounds are described.
    Type: Application
    Filed: February 7, 2014
    Publication date: August 7, 2014
    Applicants: The Trustees of the University of Pennsylvania, NuPathe, Inc.
    Inventors: Terri B. Sebree, Steven J. Siegel
  • METHODS FOR TREATING PARKINSON'S DISEASE
    Publication number: 20140178449
    Abstract: Methods for restoring normal patterns of activity in a subject suffering from Parkinson's Disease are disclosed that include administering an effective steady state concentration of a dopamine modulating compound continuously for a prolonged period of time such that normal patterns of activity are substantially restored in the subject.
    Type: Application
    Filed: October 30, 2013
    Publication date: June 26, 2014
    Applicant: NuPathe, Inc.
    Inventors: Terri B. Sebree, Steven J. Siegel
  • PHARMACOKINETICS OF IONTOPHORETIC SUMATRIPTAN ADMINISTRATION
    Publication number: 20140163452
    Abstract: Improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan are described.
    Type: Application
    Filed: November 1, 2013
    Publication date: June 12, 2014
    Applicant: NuPathe, Inc.
    Inventors: Terri B. Sebree, Mark Pierce, Carol O'Neill
  • Pharmacokinetics of iontophoretic sumatriptan administration
    Patent number: 8597272
    Abstract: Improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan are described.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: December 3, 2013
    Assignee: Nupathe, Inc.
    Inventors: Terri B. Sebree, Mark Pierce, Carol O'Neill
  • Implants for the treatment of dopamine associated states
    Patent number: 8475829
    Abstract: Biodegradable implants comprising dopamine modulating compounds are described.
    Type: Grant
    Filed: April 6, 2007
    Date of Patent: July 2, 2013
    Assignees: NuPathe Inc., The Trustees of the University of Pennsylvania
    Inventors: Terri B. Sebree, Steven J. Siegel
  • Implants for the treatment of dopamine associated states
    Patent number: 8475830
    Abstract: Biodegradable implants comprising dopamine modulating compounds are described.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: July 2, 2013
    Assignees: NuPathe Inc., The Trustees of the University of Pennsylvania
    Inventors: Terri B. Sebree, Steven J. Siegel
  • Transdermal methods and systems for the delivery of anti-migraine compounds
    Patent number: 8470853
    Abstract: Iontophoretic patches for the delivery of anti-migraine compounds and methods of using the patches are described.
    Type: Grant
    Filed: May 11, 2011
    Date of Patent: June 25, 2013
    Assignee: NuPathe Inc.
    Inventors: Carter R. Anderson, Russell L. Morris, Terri B. Sebree
  • Polyamine enhanced formulations for triptan compound iontophoresis
    Patent number: 8366600
    Abstract: A patch and compositions for iontophoresis of triptan compounds are described.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: February 5, 2013
    Assignee: NuPathe Inc.
    Inventors: Terri B. Sebree, Michael Horstmann, Mohammad Sameti
  • Pharmacokinetics of iontophoretic sumatriptan administration
    Patent number: 8155737
    Abstract: Improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan are described.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: April 10, 2012
    Assignee: NuPathe, Inc.
    Inventors: Terri B. Sebree, Mark Pierce, Carol O'Neill
  • TRANSDERMAL METHODS AND SYSTEMS FOR THE DELIVERY OF ANTI-MIGRAINE COMPOUNDS
    Publication number: 20110213330
    Abstract: Iontophoretic patches for the delivery of anti-migraine compounds and methods of using the patches are described.
    Type: Application
    Filed: May 11, 2011
    Publication date: September 1, 2011
    Applicant: NuPathe, Inc.
    Inventors: Carter R. ANDERSON, Russell L. MORRIS, Terri B. SEBREE
  • TRANSDERMAL METHODS AND SYSTEMS FOR THE DELIVERY OF ANTI-MIGRAINE COMPOUNDS
    Publication number: 20110213294
    Abstract: Iontophoretic patches for the delivery of anti-migraine compounds and methods of using the patches are described.
    Type: Application
    Filed: May 11, 2011
    Publication date: September 1, 2011
    Applicant: NuPathe, Inc.
    Inventors: Carter R. Anderson, Russell L. Morris, Terri B. Sebree
  • Transdermal methods and systems for the delivery of anti-migraine compounds
    Patent number: 7973058
    Abstract: Iontophoretic patches for the delivery of anti-migraine compounds and methods of using the patches are described.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: July 5, 2011
    Assignee: NuPathe, Inc.
    Inventors: Carter R. Anderson, Russell L. Morris, Terri B. Sebree
  • ELECTRONIC CONTROL OF DRUG DELIVERY SYSTEM
    Publication number: 20100262066
    Abstract: In an exemplary embodiment, a drug delivery device for driving an electrotransport current through a body surface of a user is provided. The device includes a patch with two electrodes and one or more reservoirs storing a therapeutic agent. The one or more reservoirs release the therapeutic agent into the body surface of the user when the reservoirs are positioned over the electrodes to form an electrical path for the electrotransport current. The device includes a controller which controls a controllable power supply to drive the electrotransport current through the body surface of the user in a predetermined profile.
    Type: Application
    Filed: December 29, 2009
    Publication date: October 14, 2010
    Applicant: NuPathe, Inc.
    Inventors: David Saar, Bogdan Mariusz Baudis, Rainuka Gupta, Vaishali Vilas Kamat, Matthew Kent Reich, Rajagopalan Srinivasan
  • Implants for the treatment of dopamine associated states
    Publication number: 20080152693
    Abstract: Biodegradable implants comprising dopamine modulating compounds are described.
    Type: Application
    Filed: February 29, 2008
    Publication date: June 26, 2008
    Applicant: NuPathe Inc.
    Inventors: Terri B. Sebree, Steven J. Siegel
  • Implants for the treatment of dopamine associated states
    Publication number: 20070269482
    Abstract: Biodegradable implants comprising dopamine modulating compounds are described.
    Type: Application
    Filed: April 6, 2007
    Publication date: November 22, 2007
    Applicant: NuPathe Inc.
    Inventors: Terri Sebree, Steven Siegel